Healthcare Systems

Name

Healthcare Systems

Legal name

株式会社ヘルスケアシステムズ

Website

https://hc-sys.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Mail-in Diagnostic & Preventive Health Testing Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industries

Food, Feed & Nutraceutical Analytical Testing (HLAGADAN), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Mail-in health testing
• Contract biomarker analysis
• Clinical research services
• Preventive health screening
• Antibody-based diagnostics

Headquarters

HQ city

Nagoya

HQ country

Japan

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Others

Revenue model

1. Mail-in Testing Services (郵送検査事業): Direct-to-consumer and corporate mail-in testing kits for various health indicators including Equol check, salt reduction tests, gut health checks, and more. Revenue generated from kit sales and analysis fees. 20+ test varieties available with 1 million cumulative tests conducted.
2. Contract Testing Services (受託検査事業): Commissioned analysis services for biological samples using ELISA, HPLC, GC, LC/MS, RT-PCR equipment. Services include biomarker development and functional food R&D for corporate clients.
3. Clinical Research Services (臨床研究事業): Clinical trial services from pilot studies to large-scale trials in partnership with corporations and municipalities. Services include trial design, IRB approval, subject recruitment, trial operations, and PR support.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels5 records

Core offering

Healthcare Systems provides mail-in health testing services for pre-symptomatic (pre-disease) health management, offering more than 20 test varieties including Equol production (Soy Check), salt reduction (Shio Check), skin barrier (Baby Well Check), gut health, immune function, oxidative stress, and gut bacteria tests. The company also offers contract testing/analysis services using ELISA, HPLC, GC, LC/MS, and RT-PCR equipment for biological and food samples, and conducts clinical research services in partnership with corporations and municipalities.

Product overview

Healthcare Systems offers a portfolio of mail-in testing services (郵送検査サービス) for pre-symptomatic health management, including tests for equol production (ソイチェック), salt reduction (シオチェック), skin barrier function (ベビウェルチェック), gut health (腸活チェック), immune function (バリアチェック), oxidative stress (サビチェック), protein intake (フレミーチェック), dust mite allergens (ダニアレルゲン検査), and gut bacteria (腸内細菌抗体検査), alongside contract testing services (ELISA, HPLC, LC/MS, PCR) and clinical research services. The company operates four business segments: Mail-in Testing, Contract Testing, Clinical Research, and Health Support, all focused on the 'pre-symptomatic' health management market.

Differentiator

Problem solved

Functional benefit

Brands

• カラダのものさし: Main consumer-facing brand for mail examination services providing various health check kits including Equol check (Soy Check), salt reduction test (Shio Check), gut health check (肠活 Check), skin barrier check, and others. Offers approximately 20 types of examination services.
• ソイチェック (Soy Check)
• ベビウェルチェック (Baby Well Check)
• シオチェック+ (Shio Check Plus)
• 肠活チェック (Intestinal Activity Check)
• サビチェック (Rust Check)
• バリアチェック (Barrier Check)

Products and services

• Karadacheck Mail-in Testing Service (からだのものさし 郵送検査) A mail-in testing platform offering approximately 20 health test varieties for consumers and corporate wellness programs, covering Equol production, salt intake, gut health, skin barrier, immune function, oxidative stress, and more.
• Soy Check - Equol Test (エクオール検査「ソイチェック」) A mail-in urine test that measures whether an individual can produce Equol from soy isoflavones, with results reported on a 5-level scale, used by corporations, health insurance associations, and individuals for women's health and menopause support.
• Shio Check - Salt Reduction Test (減塩検査「シオチェック」) A mail-in urine test that measures the sodium-to-potassium ratio (Na/K ratio) to assess salt intake and guide dietary salt reduction efforts for consumers and municipal health programs.
• Baby Well Check - Skin Barrier Test (肌バリア検査「ベビウェルチェック」) A skin barrier function test using Kao's Sebum RNA Monitoring technology to assess infant skin barrier status and provide personalized skin care recommendations; developed jointly with Kao Corporation and used in municipal childcare support programs.
• Intestinal Activity Check (腸活チェック) A mail-in urine test measuring intestinal environment health by detecting putrefactive substances (indoxyl sulfate) derived from gut bacteria.
• Barrier Check - IgA Immune Test (バリアチェック) A mail-in saliva test measuring IgA antibody levels to assess immune function status.
• Rust Check - Oxidative Stress Test (サビチェック) A mail-in urine test measuring oxidative stress (oxidation damage) in the body by detecting indicators like 8-OHdG.
• Contract Testing Services (受託検査事業) Contract analysis services for biological samples (blood, urine, saliva, tears) and food samples using ELISA, HPLC, GC, LC/MS, and RT-PCR equipment, including biomarker development and functional food research for corporate clients.
• Clinical Research Services (臨床研究事業) Clinical trial services from pilot studies to large-scale trials (hundreds of subjects) including study design, ethics committee applications, subject recruitment, trial operations, PR support, and publication services in partnership with companies and local governments.
• Health Support Services (健康支援事業) Health literacy improvement services including examination experience events at commercial facilities, food education seminars for families and youth, and other preventive health awareness programs.
• Sebum RNA Comprehensive Analysis - RNA-seq (皮脂RNA網羅解析) Comprehensive sebum RNA analysis service using Kao's Sebum RNA Monitoring technology and next-generation sequencing (NGS) for skin science, health science, and medical research applications; first-time outsourcing of Kao's technology.
• Coriobactin Test - Colorectal Cancer Risk Examination (コリバクチン検査) A colorectal cancer risk test developed by subsidiary Adenoprevent, measuring coriobactin-producing bacteria as a risk factor for colorectal cancer.

Quantifiable outcome

• 92% of participants reported improved self-care awareness through Equol testing programs at corporations
• +4 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• キリンホールディングス株式会社 (Kirin Holdings Co., Ltd.)coreStrategic or Co-development Partner · 22 May 2025Joint development of immune visualization inspection service. Kirin's Health Science Research Institute developed biomarkers for immune status visualization, and Healthcare Systems provides inspection service development and implementation. Target launch in 2026.
• 森永乳業株式会社 (Morinaga Milk Industry Co., Ltd.)coreStrategic or Co-development Partner · 20 February 2025Collaboration for Expo 2025 intestinal bacteria antibody testing. Morinaga provides booth space at Osaka Healthcare Pavilion for 'Watashi no Chokatsu Check' experience using Healthcare Systems' gut bacteria antibody test.
• 国立研究開発法人医薬基盤・健康・栄養研究所 (NIBIOHN)coreStrategic or Co-development Partner · 10 December 2024Joint development of new gut bacteria antibody test kit using proprietary antibody-based technology for rapid, low-cost analysis. Developed for Expo 2025 providing up to 40,000 tests.
• 野村不動産ライフ＆スポーツ株式会社 (Nomura Real Estate Life & Sports)minorStrategic or Co-development Partner · 10 December 2024Partnership for Megalos 'Jibun Kensa & Premium Seminar' service providing mail-in test kits combined with health seminars for corporate employee wellness.
• 花王株式会社 (Kao Corporation)coreStrategic or Co-development Partner · 4 June 2024Joint development of Baby Well Check skin barrier testing service using sebum RNA monitoring technology. Healthcare Systems provides commissioned analysis services using Kao's proprietary sebum RNA monitoring technology.
• 大阪府・大阪市・大阪万博推進委員会coreGTM or Marketing Partner · 25 March 2024Premium partner for Osaka Healthcare Pavilion at Expo 2025. Providing gut bacteria antibody tests to up to 40,000 visitors in 'Future Healthcare' zone, demonstrating personalized health management solutions.
• RNA共創コンソーシアム (RNA Co-creation Consortium)coreStrategic or Co-development Partner · 11 March 2024Founding co-creation partner in consortium led by Kao and istyle for promoting sebum RNA monitoring technology in beauty and health industry. Healthcare Systems serves as board member (幹事社).
• Precision Nutrition Implementation Platform (内阁府BRIDGE)coreStrategic or Co-development Partner · 8 February 2024Participation in precision nutrition platform with 15 organizations including universities, companies, and research institutions. Project aims to achieve individualized nutrition recommendations.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Genesis Healthcare Co. Japan's leading direct-to-consumer mail-in genetic and disease-risk testing company offering MyCode and similar services. Most directly comparable peer — overlapping at-home mail-in diagnostic model, Japanese consumer base, and corporate wellness channel.
• Cykinso Inc. Tokyo-based mail-in gut microbiome testing startup. Directly comparable in business model (mail-in kit, lab analysis, consumer health reports) and overlaps with Healthcare Systems' intestinal environment and gut bacteria antibody test products.
• Metagen Inc. Japanese mail-in gut microbiome analysis company (Mykinso). Comparable in mail-in D2C testing model, focus on gut health, and B2B/clinical research partnerships, and competes in the same 'intestinal activity' segment as Healthcare Systems.
• DeNA Co. (Mycode): Major Japanese internet company operating Mycode, a mail-in genetic testing service. Comparable as a scaled Japanese D2C mail-in health testing brand, though broader platform (gaming, healthcare) gives it incumbent advantages.
• Everlywell: US-based mail-in at-home health testing company offering 30+ tests including wellness, women's health, and chronic markers. Closest international peer to Healthcare Systems' Karadacheck platform, with broader test menu and scale.
• LetsGetChecked: Global mail-in health testing company with strong corporate wellness and consumer offerings. Comparable in mail-in kit model, lab-based biomarker analysis, and enterprise B2B wellness sales motion.
• Prenetics Group: Hong Kong-headquartered mail-in DNA and health testing company (CircleDNA). Comparable mail-in consumer testing model with Asia-Pacific distribution — a useful benchmark for Healthcare Systems' Shanghai subsidiary expansion plans.

Broad incumbents

• H.U. Group Holdings (SRL): Japan's largest clinical laboratory group (SRL) providing diagnostic testing services nationwide. Operates the traditional clinical lab infrastructure Healthcare Systems bypasses with mail-in — a relevant competitor/partner for the contract testing and clinical research segments.
• Sysmex Corporation: Global leader in in-vitro diagnostics and clinical laboratory instruments with strong Japanese roots. Comparable in biomarker/diagnostic technology platform and clinical research services, though orders of magnitude larger and oriented to B2B clinical customers.
• M3 Inc. Japan's leading medical internet platform (m3.com) with significant healthcare data, clinical research, and consumer health businesses. Relevant for Healthcare Systems' clinical research segment and as a potential distribution/scale partner in Japan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthcare Systems